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The European Heart Journal—Cardiovascular Imaging, created in 2012, has become a reference for publishing multimodality cardiovascular
imaging scientific and review papers. The impressive 2014 impact factor of 4.105 confirms the important position of our journal. In this part, we
summarize the most important studies from the journal’s third year, with specific emphasis on cardiomyopathies, congenital heart diseases,
valvular heart diseases, and heart failure.
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Cardiomyopathy
Cardiomyopathies have been discussed in several original papers.
The first review article of Borgquist et al.1 evaluated the diagnostic
performance of imaging in arrhythmogenic right ventricular cardio-
myopathy (ARVC). A significant proportion of patients with
imaging-positive ARVC by cardiac magnetic resonance (CMR) did
not fulfil echocardiographic ARVC 2010 criteria, suggesting that
the traditional echocardiographic evaluation of subtle structural
changes in the right ventricle may be less sensitive. Madonna
et al.2 highlighted the fundamental value of multimodality imaging
in patients with Fabry’s cardiomyopathy. Di Bella et al.3 also re-
ported that the latest improvements in non-invasive imaging diag-
nostic techniques with increased diagnostic power have led to a
reduced need for biopsy in patients with cardiac amyloidosis. Simi-
larly, Bossone et al.4 demonstrated that an integrated multimodality
imaging approach offers significant advantages in patients with Ta-
kotsubo cardiomyopathy (TTC). Several other studies also demon-
strated the important role of CMR tissue characterization in patients
with cardiomyopathies. Florian et al.5 evaluated extravascular vol-
ume and late gadolinium enhancement (LGE) by CMR in 27 patients
with Becker muscular dystrophy and demonstrated that 74% of
muscular dystrophy patients had LGE, and that extravascular
volume in muscular dystrophy was higher than in controls. The pres-
ence of LGE correlated with low ejection fraction and low ejection
fraction and high extracellular volume fraction were associated with
arrhythmic events. Further in 139 patients with hypertrophic car-
diomyopathy (HCM), Ellims et al. evaluated the phenotype and in-
vestigated links between genotype and phenotype. They observed
that compared with healthy subjects those with HCM manifest low-
er post-contrast myocardial T1 times, suggestive of more diffuse
myocardial fibrosis, and a greater quantity of LGE, consistent with
more regional myocardial fibrosis.6 Furthermore, HCM patients
with an identifiable genetic mutation had evidence of significantly
more regional, but less diffuse, myocardial fibrosis, than patients
without mutations. They did not demonstrate significant associa-
tions between individual HCM mutations and specific phenotypic
characteristics. Interestingly, Geske et al.7 showed that the echocar-
diographic regional strain differences in genotyped HCM patients
are dependent on septal morphology or thickness, but not on geno-
type. Also in patients with HCM, Gyllenhammar evaluated myocar-
dial perfusion by phase-contrast mitral regurgitation (MR) in the
coronary sinus at rest and during adenosine and compared it against
healthy controls and patients at risk, but HCM.8 They showed that
young patients with HCM have significantly lower myocardial perfu-
sion during adenosine compared with controls, this decrease is
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found in HCM patients without diastolic dysfunction or left ven-
tricular (LV) outflow tract obstruction, and MP in young subjects
at HCM risk is similar to controls.
Diabetic cardiomyopathy is defined as diastolic or systolic myo-
cardial disease in the absence of valvular dysfunction, coronary ar-
tery disease, and hypertension. In young adults with Type 2
diabetes mellitus, diabetes duration and aortic distensibility are asso-
ciated with diastolic dysfunction.9 Whether medical treatment may
revert these structural anomalies has been examined by Jellis et al.
Surprisingly, spironolactone-induced changes in myocardial struc-
ture and diastolic properties in these patients were not associated
with changes in collagen biomarkers or CMR T1 values.10
The pathophysiology of Takotsubo syndrome continues to be
elusive. Whether myocardial hypoperfusion is the cause or a conse-
quence of TTC has been evaluated in a rat model of stress-induced
TTC. Redfors et al.11 showed that apical perfusion was not impaired
in the early phase of stress-induced TTC. In patients with TTC, the
LV recovery consists of two components. The first component is a
rapid systolic recovery with a minimal diastolic recovery, whereas
the second component is a postponed diastolic recovery accom-
panied by a minor residual systolic recovery.12
LV non-compaction is a rare but challenging cardiomyopathy. Pe-
ters et al.13 showed that LV twist, an important component of sys-
tolic function, as assessed by 2D speckle tracking echocardiography,
was diminished in these patients through normal LV rotation. Car-
diac resynchronization therapy (CRT) has become a mainstay in
heart failure management, but still 30% of patients failed to respond
to therapy. Although imaging plays an important role in heart failure
patients, no standardized method has been shown to be superior to
another to evaluate potential responders to CRT. Bakos et al.14
showed that identifying and presenting a target segment for LV
lead implantation in CRT is feasible preoperatively, using a bullseye
plot with combined data from computed tomography (CT), CMR,
and echocardiography (Figure 1). In 40 heart failure patients, Djord-
jevic Dikic et al.15 demonstrated that preserved coronary flow
reserve in patients with dilated cardiomyopathy is predictive of
LV improvement after CRT implantation.
Finally, two papers emphasized the role of CMR in myocarditis. In
the June issue of the journal, Lurz et al.16 evaluated the incremental
role of pericardial effusion to a comprehensive CMR imaging proto-
col, in 132 patients undergoing endomyocardial biopsy for the diagno-
sis of myocarditis. They found that pericardial effusion was a common
finding on CMR imaging in patients with suspected myocarditis mainly
in patients with a shorter duration of symptoms. However, the pres-
ence of PE was found to be not specific for the diagnosis of myocar-
ditis and did not improve the overall diagnostic accuracy of cardiac
MR for the diagnosis of myocarditis. In the October issue of the jour-
nal, Vermes et al.17 reported in 37 patients referred for acute myocar-
ditis the prognostic value of CMR for LV functional improvement.
They found that patients with the Lake-Louise + criteria had signifi-
cantly lower ejection fraction at baseline and follow-up, but was asso-
ciated with improvement of dysfunction. Among these criteria,
myocardial oedema on T2-weighted MR image was the strongest
predictor of recovery, indicating that that recovery of dysfunction
likely reflects recovery of reversibly injured myocardium.
Cardiac CT is a well-established imaging modality for the assess-
ment of coronary artery disease. CT has also recently emerged as a
valuable tool to examine myocardial pathology, due to its excellent
patient compatibility and tolerability, high spatial resolution, and
acceptable tissue characterization. Two review articles18,19 high-
lighted the possibilities of cardiac CT in detecting myocardial path-
ology and evaluating structural abnormalities associated with
cardiomyopathies and congenital heart diseases. This information
should be kept in mind when performing coronary CT angiography
and CT may also be useful in patients for whom other imaging
techniques, particularly magnetic resonance imaging (MRI), are
not suitable.
[18F]fluorodeoxyglucose (FDG) accumulation is increased in the
right ventricular (RV) free wall of patients with pulmonary hyperten-
sion. The results of Tatebe et al.20 indicate that enhanced FDG ac-
cumulation reflecting impaired RV substrate metabolism in the
pressure overloaded RV free wall may be a prognostic factor in pa-
tients with pulmonary hypertension. In 27 patients and .5 years of
follow-up, high RV standardized uptake value of FDG-positron
emission tomography significantly predicted combined end-point
of cardiovascular clinical worsening, including all-cause mortality,
lung transplantation, hospitalization for the progression of pulmon-
ary hypertension, and deterioration of WHO functional class and/or
reduction in 6 min walking distance.
Congenital heart disease
Several studies demonstrated the increasing role multimodality im-
aging in congenital heart disease. Orwat et al.19 described, in an ele-
gant review article, the current armamentarium of imaging tools
available to the adult congenital heart disease cardiologist and put
emphasises on the usefulness of advanced imaging modalities. Ment-
ing et al.21 performed speckle tracking echocardiography and car-
diac MR in 82 patients with repaired tetralogy of Fallot. They
observed that 29% of patients with tetralogy of Fallot had abnormal
twist by speckle tracking echocardiography. This was associated
with larger LV dimensions and decreased LV and RV systolic func-
tion and this suggests that such abnormal twist could be a new ob-
jective diagnostic criterion for detection of ventricular dysfunction.
Jing et al.22 used MR feature tracking computation of strains in pa-
tients with repaired tetralogy of Fallot and demonstrated that these
patients had intra- and interventricular dyssynchrony related to
their RV bundle branch block and that this dyssynchrony correlated
with LV but not RV dysfunction. Bell et al.23 evaluated the ability of
real-time 3D echocardiography to assess RV function in 41 infants
with hypoplastic left heart syndrome and compared these measure-
ments with cardiac MR as reference method. They found that
real-time 3D echocardiography was well correlated with CMR,
and highly reproducible. However, the measurements obtained by
3D echocardiography were significantly lower than those obtained
by CMR, with wide limits of agreement such that these two methods
cannot be used interchangeably. Finally, Jimenez-Juan et al.24 evalu-
ated pregnancy outcomes in 28 women with aortic coarctation with
respect to aortic morphometry by 3D-contrast enhanced MR angi-
ography. They found that minimal aortic diameter related to the
odds of developing a cardiovascular event during pregnancy, and
that a minimum aortic diameter ≤12 mm was identified as an im-
portant anatomic determinant of adverse cardiovascular outcomes,
and in particular hypertensive crisis. This aortic dimension may help
B.L. Gerber et al.Page 2 of 5






identify women at low risk of adverse events in pregnancy and those
who would benefit from intervention prior to and/or heightened
surveillance during pregnancy. Manganaro et al.25 reviewed the lit-
erature about accessory mitral valve tissue, which is a rare congeni-
tal cardiac anomaly where an imaging plays a major diagnostic role.
Labombarda et al.26 highlighted the usefulness of trans-thoracic
echocardiography for initial screening of major coronary anomalies
in children and adults. However, when the diagnosis is made or sus-
pected, the imaging work-up has to be completed by CT or CMR
angiogram or coronary angiography. Atrial septal defect (ASD) is
one of the most common congenital heart diseases in adults.
Whether percutaneous closure of secundum ASD can affect left at-
rial (LA) mechanical functions has been examined by Aslan et al.27 in
41 patients. The authors showed no change in the LA mechanical
reservoir functions, but improved conduit function and impaired
contractility functions early and in the mid-term after percutaneous
closure of ASD.
Valvular heart diseases
Several original articles have been published on valvular heart dis-
eases. Secondary MR is frequent in patients with aortic stenosis.
In a series of 172 patients, 63% of the patients had secondary MR.
The association between the severity of aortic stenosis and effective
regurgitant orifice was not significant. LV function was found to be a
main determinant of secondary MR, even in the patients in whom LV
ejection function was preserved.28
Quantification of aortic regurgitation (AR), even when an inte-
grated approach is used, remains difficult. There are several limita-
tions in the assessment of quantitative parameters. In particular,
when the proximal isovelocity surface area is used, a hemispheric as-
sumption of the flow convergence zone is one of these limitations.
Multi-beam high-pulse repetition frequency (HPRF) colour Doppler
was used to quantify the vena contracta area in 29 patients with mild
to severe AR. CMR was used as the standard of reference. The
agreement between CMR and multi-beam HPRF colour Doppler
was good in patients with severe or moderate AR but the agree-
ment was modest for those with mild AR.29
CMR was compared with trans-thoracic echocardiography in 31
patients with isolated mitral stenosis in sinus rhythm. Good correla-
tions between the two methods were found for the measurements
of trans-mitral diastolic velocities and planimetric mitral valve area.
CMR appears to be a reliable tool in patients with mitral stenosis.30
3D trans-thoracic echocardiography, using LV volumes was used
for a quantitative assessment of primary MR. Regurgitant fraction
was calculated from 2D echo or 3D LV volumes. The 3D method
had a high feasibility of 90%. The inter-reader concordance for
MR grading was excellent (k-value of 0.90). The authors suggest
that this parameter could be included in the multiparameter integra-
tive approach for evaluating primary MR.31
Figure 1 Schematic representation of how the appropriate target segment for cardiac resynchronization was selected. Four bullseye plots to-
gether with colour coding. Plot (A) shows echocardiography data, the segment with latest mechanical activation is red, neighbouring segments with
late activation are yellow and remote segments are grey. Plot (B) shows CT data, segments with one or more suitable vein branches are highlighted.
Plot (C) shows MRI data, viable segments are grey, segments with non-transmural infarction (,50%) are yellow, and segments with transmural
infarction (≥50%) are red. The final plot (D) shows the optimal segment (green), acceptable adjacent segments (yellow), and non-suitable or
remote segments (grey). MRI, magnetic resonance imaging; CT, computed tomography. (From Bakos et al.14)
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3D transoesophageal echocardiography was performed in 72 pa-
tients with secondary MR. By measuring mitral annular area and leaf-
let area in early and late systole, the authors defined mitral annular
area fractional change and coaptation index as the strongest predic-
tors of MR. They emphasize the importance of LA dilatation that
leads to mitral annular area enlargement, reduces leaflet coaptation,
and produces MR.32
Two articles dealt with mechanical prosthetic valve dysfunction.
A review paper based on a literature search included 238 mechan-
ical prosthetic valves with obstruction with a reliable reference
standard. Thromboses were characterized by leaflet restriction
identified by fluoroscopy and mass detection by transoesophageal
echo (TOE). When prosthetic valve obstruction related to a pannus,
mass detection was absent in the majority of cases. The authors pro-
vided a diagnostic algorithm for correctly identifying patients with
non-thrombotic prosthetic valve obstruction in whom thrombolysis
is contraindicated.33
MitraClip implantation is increasingly used in high-risk patients
with secondary MR. A study from Pisa included 35 patients who
underwent percutaneous mitral valve repair. The procedure re-
sulted in significantly reduced MR, improvement in LV size, and func-
tion at discharge. A further improvement at 6 months was observed.
There was also a significant improvement in RV function: tricuspid
annulus plane systolic excursion and systolic velocity at the tricuspid
annular increased significantly; the systolic pulmonary pressures
were significantly reduced before discharge and at follow-up.34
Tricuspid regurgitation (TR) is frequently observed in patients
with secondary MR. Percutaneous mitral valve repair was per-
formed in 146 consecutive patients with secondary MR. The popu-
lation was separated into two groups according to the degree of TR.
The MitraClip implantation was associated with improvement
in MR, TR, and functional class. However, moderate or severe TR
predicted independently death and hospitalization for heart failure
at 1 year.35
Although TOE is usually performed to guide septal puncture dur-
ing percutaneous mitral commissurotomy, intracardiac echocardi-
ography is another possible approach. TOE, aortic, and venous
intracardiac echo were performed in 50 patients with mitral sten-
osis. It was shown that both the fossa ovalis and the tip of the needle
were better visualized with aortic intracardiac echo which appears
to be more reliable than venous intracardiac echo to facilitate trans-
septal puncture in patients with mitral stenosis.36
Transvenous lead extraction is increasingly required. It is a rela-
tively safe procedure, although intractable haemodynamic instability
can occur rarely. TOE was required in 26 patients. In 14 patients, life
threatening cardiovascular injury was excluded by TOE. In 10 pa-
tients, pericardial effusion was diagnosed and 2 patients developed
haemorrhagic shock. Rescue TOE helps to identify the aetiology of
haemodynamic instability leading to appropriate intervention.37
Transcatheter aortic-valve implantation (TAVI) improves prog-
nosis of high-risk patients with severe aortic stenosis. The effects
of TAVI on LA and LV mechanics were studied in 54 consecutive
patients. LV global and regional longitudinal deformation and LA
function were determined by speckle tracking echocardiography.
Global and regional LV and LA mechanics were improved; the ef-
fects were most pronounced in the patients with paradoxical
low-flow.38
Calcium in the aortic-valve complex is predictive of paravalvular
leak after TAVI. Jilaihawi et al.39 optimized methodology for quanti-
fication of the aortic-valve calcium in 198 preoperative CT scans for
the prediction of significant paravalvular leak after TAVI. Both leaflet
and LVOT calcium were significant predictors of paravalvular leak,
even in appropriately sized valves. However, the ability of calcium
quantification to predict paravalvular leak after TAVI depends heav-
ily on the thresholds set to detect calcium. With careful attention to
these thresholds, clinically relevant leaflet calcium volumes can be
identified with either non-contrast or contrast CT scans.
Heart failure
It is well known that LA size provides prognostic information in vari-
ous cardiovascular diseases. In a large series of CARDIA partici-
pants, LA size predicted clinical outcome, including myocardial
infarction, heart failure, cerebrovascular disease, peripheral arterial
disease, and atrial fibrillation. It was found that indexing LA size by
height is at least as robust as by body surface area. LA size improves
modestly discrimination over clinical parameters without altering
risk classification.40
Non-longitudinal LV function can be assessed by mitral annular
displacement or systolic velocity using M-mode, colour tissue Dop-
pler imaging, and 2D strain imaging. A series of 168 patients with
various cardiac anomalies were studied. Tissue Doppler imaging
had the lowest observed variability and the authors concluded
that this method seems to be the most robust tool.41
Non-invasive assessment of LV filling pressure is increasingly used
in daily clinical practice by the ratio between trans-mitral E velocity
and early diastolic velocities (e′) usually by averaging of septal and
lateral velocities. However, the E/e′ ratio has limitations and has
been challenged in patients with MR, preserved LV function, or ad-
vanced heart failure. Therefore, the EURO-FILLING study aims to
compare simultaneous assessment of invasive and non-invasive
measurements of LV filling pressure. This study will contribute to
the standardization of this assessment.42
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